20 results
8-K
EX-99.1
OLMA
Olema Pharmaceuticals, Inc.
8 Jan 24
Olema Oncology JP Morgan Conference January 2024
9:07am
Complete ER antagonists turn off AF2and recruit N-CoR to inactivate AF1 Palazestrant Palazestrant (CERAN/SERD) Complete ER Antagonism CERAN
10-Q
5hkm 7ivi02elmkx
11 May 21
Quarterly report
4:22pm
10-K
umb i73val
17 Mar 21
Annual report
4:21pm
424B4
pokl2
19 Nov 20
Prospectus supplement with pricing info
4:43pm
S-1/A
rrwdvt7nr
16 Nov 20
IPO registration (amended)
6:06am
S-1
0hvgf7mdlrybokxrskr
30 Oct 20
IPO registration
2:29pm
DRS/A
pr8wodqg
23 Oct 20
Draft registration statement (amended)
12:00am
DRS
2trw8y3a 3wx
21 Sep 20
Draft registration statement
12:00am
- Prev
- 1
- Next